Joint Associations of Sedentary Time and Intensity-Specific Physical Activity With Cancer Mortality: A Device-Based Cohort Study of 72,458 UK Adults

Sedentary time has been associated with higher risk of cancer mortality, independent of physical activity (PA).1 However, questionnaire-based findings from a harmonized meta-analysis suggested that at least 50 to 65 minutes per day of self-reported moderate to vigorous PA eliminated the association...

Descripción completa

Detalles Bibliográficos
Autores: Rezende, Leandro, Ahmadi, Matthew, Ferrari, Gerson, Pozo Cruz, Borja del, Lee, I-Min, Friedenreich, Christine M, Stamatakis, Emmanuel
Tipo de recurso: artículo
Fecha de publicación:2025
País:España
Institución:Universidad Europea (UEM)
Repositorio:ABACUS. Repositorio de Producción Científica
Idioma:inglés
OAI Identifier:oai:abacus.universidadeuropea.com:11268/14149
Acceso en línea:http://hdl.handle.net/11268/14149
Access Level:acceso abierto
Palabra clave:Sedentarismo
Deporte
Goal 3: Ensure healthy lives and promote well-being for all at all ages
Descripción
Sumario:Sedentary time has been associated with higher risk of cancer mortality, independent of physical activity (PA).1 However, questionnaire-based findings from a harmonized meta-analysis suggested that at least 50 to 65 minutes per day of self-reported moderate to vigorous PA eliminated the association between sedentary time and cancer mortality.2 Contrary to questionnaires that only capture blocks of PA (eg, 10–15 min of walking), wearable devices capture all movement and allow the differentiation of PA intensities, such as short bouts of vigorous intermittent lifestyle PA3,4 and light PA (LPA). To our knowledge, no wearable device-based study on the joint association of sedentary time and PA with cancer mortality exists.5 Understanding the amounts of movement at different intensities that attenuate the association between sedentary time and cancer mortality may help to inform future guidelines. We examined the joint association of sedentary time and intensity-specific PA with cancer mortality in UK adults.